Strategies for developing novel therapeutics for sensorineural hearing loss
Sensorineural hearing loss (SNHL) is a common disability in the world; however, at present, options for the pharmacological treatment of SNHL are very limited. Previous studies involving human temporal bone analyses have revealed that the degeneration of the cochlea is a common mechanism of SNHL. A...
Main Author: | Takayuki eNakagawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00206/full |
Similar Items
-
Future Pharmacotherapy for Sensorineural Hearing Loss by Protection and Regeneration of Auditory Hair Cells
by: Mami Matsunaga, et al.
Published: (2023-02-01) -
Vulnerable frequency as an independent prognostic factor for sudden sensorineural hearing loss
by: Chaoqun Liang, et al.
Published: (2022-09-01) -
Stem Cell Therapy in Children With Sensorineural Hearing Loss: A Narrative Review
by: Mahbobeh Oroei, et al.
Published: (2021-07-01) -
Oxidative stress and inflammation combine to exacerbate cochlear damage and sensorineural hearing loss in C57BL/6 mice
by: Zhongwu Su, et al.
Published: (2025-03-01) -
Stem cell therapy in sensorineural hearing loss: a systematic review
by: Ossama Mustafa Mady, et al.
Published: (2023-10-01)